Gary R. Point

Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA+ Liver Metastases

Steven C. Katz, Rachel A. Burga, Elise McCormack et al. · Clinical Cancer Research · 2015 · 371 citations

Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T

Rachel A. Burga, Mitchell Thorn, Gary R. Point et al. · Cancer Immunology Immunotherapy · 2015 · 212 citations · Full text

Cancer Immunosurveillance, Hepatocellular Carcinoma, Liver Physiology +9

Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery

Steven C. Katz, Gary R. Point, Marissa Cunetta et al. · Cancer Gene Therapy · 2016 · 168 citations · Full text

Cell Therapy, Immunotherapy, Peritoneal Carcinomatosis +8

PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor

Hua Xu, Michael I. Jesson, Uthpala Seneviratne et al. · ACS Chemical Biology · 2019 · 152 citations

Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells

Mitchell Thorn, Gary R. Point, Rachel A. Burga et al. · Journal of Leukocyte Biology · 2014 · 16 citations · Full text